DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of Confirmation/Duplicate Share certificate26-07-2023
26-07-2023
Q1FY24 Quarterly Result Announced for Dr. Reddy's Laboratories Ltd.
Pharmaceuticals company Dr. Reddy's Laboratories announced Q1FY24 results: Revenues of Rs 67,384 million, Up 29% YoY; Up 7% QoQ Gross margin of 58.7% (Q1FY23: 49.9%; Q4FY23: 57.2%) SG&A; expenses of Rs 17,702 million (Up 14% YoY; Down 2% QoQ) R&D; expenses of Rs 4,984 million (7.4% of Revenues) EBITDA of Rs 21,372 million (31. 7% of Revenues) Profit before tax of Rs 18,463 million (Up 26% YoY; Up 39% QoQ) Profit after tax of Rs 14,025 million (Up 18% YoY; Up 46% QoQ) Commenting on the results, Co-Chairman & MD, G V Prasad, said: "We delivered strong sales growth and witnessed robust margin expansion in Q1FY24 driven by market share gains & new product momentum in our US generics business and superior performance in Russia. We are on track in executing our strategy, delivering growth while continuing to invest in future growth drivers and innovation to create sustainable value." Result PDF26-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Retirement
Retirement of Mr. Sridar Iyengar (DIN:00278512), Independent Director of the Company26-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Results-Press Release26-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Unaudited Financial Results For Quarter Ended June 30, 2023
Unaudited Financial results for quarter ended June 30, 202326-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)
Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015 (SEBI Listing Regulations)26-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30, 2023
Outcome of Board Meeting - Unaudited Financial Results for the quarter ended June 30, 202326-07-2023
Dr Reddy Share Price Live blog for 26 Jul 2023
Dr Reddy stock price went up today, 26 Jul 2023, by 0.64 %. The stock closed at 5391.75 per share. The stock is currently trading at 5426.3 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.26-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity shares on exercise of stock options under ESOPs25-07-2023
Dr Reddy Share Price Live blog for 25 Jul 2023
Dr Reddy stock price went up today, 25 Jul 2023, by 1.99 %. The stock closed at 5287.7 per share. The stock is currently trading at 5392.7 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.25-07-2023